Enhancing Psychosis Risk Prediction Through Computational Cognitive Neuroscience.


Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
01 12 2020
Historique:
pubmed: 11 7 2020
medline: 26 10 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

Research suggests that early identification and intervention with individuals at clinical high risk (CHR) for psychosis may be able to improve the course of illness. The first generation of studies suggested that the identification of CHR through the use of specialized interviews evaluating attenuated psychosis symptoms is a promising strategy for exploring mechanisms associated with illness progression, etiology, and identifying new treatment targets. The next generation of research on psychosis risk must address two major limitations: (1) interview methods have limited specificity, as recent estimates indicate that only 15%-30% of individuals identified as CHR convert to psychosis and (2) the expertise needed to make CHR diagnosis is only accessible in a handful of academic centers. Here, we introduce a new approach to CHR assessment that has the potential to increase accessibility and positive predictive value. Recent advances in clinical and computational cognitive neuroscience have generated new behavioral measures that assay the cognitive mechanisms and neural systems that underlie the positive, negative, and disorganization symptoms that are characteristic of psychotic disorders. We hypothesize that measures tied to symptom generation will lead to enhanced sensitivity and specificity relative to interview methods and the cognitive intermediate phenotype measures that have been studied to date that are typically indicators of trait vulnerability and, therefore, have a high false positive rate for conversion to psychosis. These new behavioral measures have the potential to be implemented on the internet and at minimal expense, thereby increasing accessibility of assessments.

Identifiants

pubmed: 32648913
pii: 5869747
doi: 10.1093/schbul/sbaa091
pmc: PMC7707066
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1346-1352

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH115031
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112612
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH120091
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH120092
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH120089
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH119438
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112613
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH120088
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH081988
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112545
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH120090
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116039
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Références

Schizophr Res. 2014 Jan;152(1):309-10
pubmed: 24332796
Schizophr Bull. 2003;29(4):771-90
pubmed: 14989414
Br J Psychiatry. 2013 Jul;203(1):58-64
pubmed: 23703317
Schizophr Res. 2011 Nov;132(2-3):213-9
pubmed: 21907547
Am J Psychiatry. 2012 Apr;169(4):364-73
pubmed: 22407079
Biol Psychiatry. 2020 Jul 15;88(2):e5-e10
pubmed: 32113656
Schizophr Bull. 2003;29(4):703-15
pubmed: 14989408
Psychol Med. 2018 Apr;48(6):889-904
pubmed: 28889803
Clin Psychol Sci. 2018 Sep 1;6(5):721-734
pubmed: 30319928
Biol Psychiatry. 2014 Mar 15;75(6):459-69
pubmed: 24050720
Schizophr Res. 2011 Oct;132(1):8-17
pubmed: 21784618
Biol Psychiatry. 2017 Jan 1;81(1):31-42
pubmed: 27206569
Brain. 2017 Sep 1;140(9):2475-2489
pubmed: 29050393
PLoS Biol. 2016 Nov 15;14(11):e1002575
pubmed: 27846219
Science. 2017 Aug 11;357(6351):596-600
pubmed: 28798131
JAMA Psychiatry. 2013 Aug;70(8):793-802
pubmed: 23739772
Arch Gen Psychiatry. 2008 Jan;65(1):28-37
pubmed: 18180426
Biol Psychiatry. 2017 Sep 15;82(6):431-439
pubmed: 28651789
Trends Neurosci. 2019 Mar;42(3):205-220
pubmed: 30621912
Biol Psychiatry. 2017 Jan 1;81(1):52-66
pubmed: 27452791
Neuropharmacology. 2020 Jun 15;170:108053
pubmed: 32188568
Schizophr Res. 2020 Jun 24;:
pubmed: 32593735
Schizophr Bull. 2006 Jan;32(1):179-94
pubmed: 16166612
Arch Gen Psychiatry. 2012 Feb;69(2):129-38
pubmed: 22310503
Br J Psychiatry. 1997 Dec;171:502-8
pubmed: 9519087
Eur Psychiatry. 2012 Apr;27(3):181-91
pubmed: 21940151
J Abnorm Psychol. 2019 Oct;128(7):710-722
pubmed: 31282687
Schizophr Bull. 2009 May;35(3):509-27
pubmed: 19155345
Schizophr Res. 2018 Feb;192:364-370
pubmed: 28629890
Am J Psychiatry. 2003 Jan;160(1):13-23
pubmed: 12505794
Early Interv Psychiatry. 2013 Feb;7(1):80-3
pubmed: 22741608
Eur Psychiatry. 2015 Mar;30(3):405-16
pubmed: 25735810
Front Hum Neurosci. 2009 Jul 10;3:12
pubmed: 19636384
JAMA Psychiatry. 2015 Dec;72(12):1172-81
pubmed: 26509694
Am J Psychiatry. 2016 Oct 1;173(10):989-996
pubmed: 27363511
Nat Rev Neurosci. 2009 Jan;10(1):48-58
pubmed: 19050712
Schizophr Bull. 2009 Sep;35(5):894-908
pubmed: 19386578
Psychol Med. 2014 Jan;44(1):17-24
pubmed: 23414600
J Abnorm Psychol. 2017 Jul;126(5):694-711
pubmed: 28406662
Br J Psychiatry Suppl. 2007 Dec;51:s13-8
pubmed: 18055930
Arch Gen Psychiatry. 2010 Mar;67(3):241-51
pubmed: 20194824
World Psychiatry. 2017 Jun;16(2):200-206
pubmed: 28498576
Prog Neurobiol. 2010 Nov;92(3):345-69
pubmed: 20558235
Curr Biol. 2018 Feb 19;28(4):503-514.e4
pubmed: 29398218
Schizophr Bull. 2007 May;33(3):673-81
pubmed: 17404389
Biol Psychiatry. 2013 Sep 15;74(6):410-7
pubmed: 23562006
Early Interv Psychiatry. 2018 Dec;12(6):1188-1192
pubmed: 28597553
Aust N Z J Psychiatry. 1996 Oct;30(5):587-99
pubmed: 8902166
Schizophr Bull. 2008 Sep;34(5):835-47
pubmed: 18591195
Schizophr Res. 2016 Jan;170(1):130-6
pubmed: 26673973
Schizophr Res. 2006 Jan 1;81(1):75-82
pubmed: 16309892
World Psychiatry. 2005 Oct;4(3):161-7
pubmed: 16633542
Am J Psychiatry. 2002 May;159(5):863-5
pubmed: 11986145
Neuropsychopharmacology. 2011 Aug;36(9):1781-91
pubmed: 21508933
CNS Spectr. 2018 Jun;23(3):187-191
pubmed: 29954475
Conscious Cogn. 2015 Nov;36:390-405
pubmed: 25563935
Nat Neurosci. 2018 Aug;21(8):1019-1021
pubmed: 30038278
Psychol Bull. 2005 Jul;131(4):618-632
pubmed: 16060805
Trends Cogn Sci. 2009 Jul;13(7):293-301
pubmed: 19559644
Psychopharmacology (Berl). 2009 Nov;206(4):515-30
pubmed: 19475401
J Neurosci. 2014 Oct 8;34(41):13747-56
pubmed: 25297101
Schizophr Res. 2014 Feb;152(2-3):391-9
pubmed: 24387999
Aust N Z J Psychiatry. 2000 Nov;34 Suppl:S164-9
pubmed: 11129303
Schizophr Bull. 2003;29(4):633-51
pubmed: 14989404
Am J Psychiatry. 2016 Oct 1;173(10):980-988
pubmed: 27363508
Schizophr Res. 2017 Nov;189:43-49
pubmed: 28189529
Eur Psychiatry. 2005 Aug;20(5-6):372-8
pubmed: 16171652
Psychol Med. 2019 Sep;49(12):1990-1998
pubmed: 30213278
Schizophr Bull. 2017 Mar 1;43(2):263-272
pubmed: 28177090
Neuroimage Clin. 2019;23:101862
pubmed: 31150956
Schizophr Bull. 2016 May;42(3):732-43
pubmed: 26591006
JAMA Psychiatry. 2017 Jan 1;74(1):19-27
pubmed: 27893018
J Psychopharmacol. 2007 May;21(3):238-52
pubmed: 17591652
J Psychiatr Res. 2019 Jan;108:57-83
pubmed: 30055853
Am J Psychiatry. 2016 Apr 1;173(4):362-72
pubmed: 26481174
Cogn Neuropsychiatry. 2016;21(1):73-89
pubmed: 26878311
Brain. 2018 May 1;141(5):1455-1469
pubmed: 29672668
Biol Psychiatry. 2018 Nov 1;84(9):634-643
pubmed: 30007575
Biol Psychiatry. 2008 Jul 1;64(1):62-9
pubmed: 18377874
Front Psychiatry. 2013 May 30;4:47
pubmed: 23750138
J Nerv Ment Dis. 2015 May;203(5):342-51
pubmed: 25919384
Early Interv Psychiatry. 2015 Jun;9(3):200-6
pubmed: 24224963
Front Psychiatry. 2019 Apr 17;10:174
pubmed: 31057431
Behav Brain Sci. 2003 Feb;26(1):65-82; discussion 82-137
pubmed: 14598440
Schizophr Res. 2017 Feb;180:48-57
pubmed: 27595552
NPJ Schizophr. 2018 Jun 25;4(1):11
pubmed: 29941938
Nat Rev Neurosci. 2019 Dec;20(12):763-778
pubmed: 31712782
Arch Gen Psychiatry. 2012 Mar;69(3):220-9
pubmed: 22393215
Biol Psychiatry. 2015 Jan 15;77(2):147-57
pubmed: 25034946
Arch Gen Psychiatry. 2010 Jun;67(6):578-88
pubmed: 20530007
Psychiatr Rehabil J. 2006 Summer;30(1):54-60
pubmed: 16881246
Trends Cogn Sci. 2019 Feb;23(2):114-127
pubmed: 30583945
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Mar;4(3):280-290
pubmed: 30683607
J Psychopharmacol. 2015 Feb;29(2):97-115
pubmed: 25586400
JAMA Psychiatry. 2019 Nov 1;76(11):1187-1197
pubmed: 31389974
Schizophr Bull. 2014 Nov;40(6):1404-11
pubmed: 24903414
Biol Psychiatry. 2015 Dec 1;78(11):747-53
pubmed: 26049208
Curr Top Behav Neurosci. 2016;27:411-49
pubmed: 26026289
Curr Top Behav Neurosci. 2016;27:375-410
pubmed: 26370946
Psychiatry Res. 2019 Sep;279:9-14
pubmed: 31279247
Am J Med Genet. 2002 Dec 8;114(8):956-66
pubmed: 12457393

Auteurs

James M Gold (JM)

Department of Psychiatry and Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.

Philip R Corlett (PR)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT.

Gregory P Strauss (GP)

Department of Psychology, University of Georgia, Athens, GA.

Jason Schiffman (J)

University of Maryland, Baltimore, MD.

Lauren M Ellman (LM)

Department of Psychology, Temple University, Philadelphia, PA.

Elaine F Walker (EF)

Department of Psychology, Emory University, Atlanta, GA.

Albert R Powers (AR)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT.

Scott W Woods (SW)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT.

James A Waltz (JA)

Department of Psychiatry and Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD.

Steven M Silverstein (SM)

Departments of Psychiatry, Neuroscience, and Ophthalmology, University of Rochester Medical Center, Rochester, NY.

Vijay A Mittal (VA)

Departments of Psychology, Psychiatry, Medical Social Sciences, Institutes for Policy Research (IPR) and Innovations in Developmental Sciences (DevSci), Evanston and Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH